Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1979-09-27
1981-03-10
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
A61K 3330
Patent
active
042554195
ABSTRACT:
Low serum zinc concentrations in humans have been associated with multiple sclerosis in some patients, particularly those patients under 50 years of age. Increasing the concentration of serum zinc in such patients has been found to lower the number of, or decrease the severity of recurrent attacks and/or improve neurologic function in some patients.
REFERENCES:
The Merck Manual, 12th Ed. (1972), pp. 1333-1342, Merck & Co., Rahway, N.J.
Allergan Pharmaceuticals, Inc.
Voet Martin A.
Waddell Frederick E.
LandOfFree
Zinc deficiency in multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc deficiency in multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc deficiency in multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1294098